本文選題：科學(xué)知識(shí)社會(huì)學(xué)　切入點(diǎn)：衛(wèi)生政策　出處：《自然辯證法通訊》2017年05期

【摘要】：基本藥物的理念最初是由世界衛(wèi)生組織在20世紀(jì)70年代提出,中國(guó)是最早著手起草并擁有國(guó)家基本藥物目錄的少數(shù)國(guó)家之一,于2009年將其確立為中國(guó)新醫(yī)改的四項(xiàng)基本制度之一�；舅幬飶氖澜缧l(wèi)生組織的一個(gè)目錄逐漸演化為一個(gè)制度經(jīng)過(guò)了一個(gè)較長(zhǎng)的歷史過(guò)程,本文從科學(xué)史與科學(xué)知識(shí)社會(huì)學(xué)的進(jìn)路分析基本藥物的政策和制度在中國(guó)的演化歷程,圍繞基本藥物的話(huà)語(yǔ)轉(zhuǎn)變,探究其背后隱藏的各種社會(huì)經(jīng)濟(jì)、醫(yī)藥技術(shù)、政府責(zé)任的影響,國(guó)內(nèi)政策與國(guó)際關(guān)系的互動(dòng),以及國(guó)際組織—國(guó)家政府—制藥企業(yè)之間的張力。
[Abstract]:The idea of essential drugs was first put forward by the World Health Organization in the 1970s. China was one of the few countries to start drafting and having a national catalogue of essential drugs. In 2009, it was established as one of the four basic systems in China's new health care reform. The evolution of essential drugs from a World Health Organization directory to a system has gone through a long historical process. This paper analyzes the evolution of the policies and systems of essential drugs in China from the perspective of the history of science and the sociology of scientific knowledge. The impact of government responsibility, the interaction between domestic policy and international relations, and the tension between international organizations, national governments and pharmaceutical companies.
【作者單位】： 北京大學(xué)醫(yī)學(xué)人文研究院;
【基金】：北京大學(xué)醫(yī)學(xué)部公共教學(xué)部青年科研基金支持,項(xiàng)目編號(hào)為GJBQ201509
【分類(lèi)號(hào)】：R951
，

本文編號(hào)：1652995